
Neochem Bio Solutions Limited IPO
Neochem Bio Solutions Limited IPO is a SME book building IPO. Issue size is 44.97 Cr. Price band is ₹93 to ₹98 per share. Minimum investment is ₹2.35 L. Lot size is 1200 shares. Open from 2 Dec 2025 to 4 Dec 2025. Allotment on 5 Dec 2025. Listing on 9 Dec 2025 at NSE. Managed by Vivro Financial Services Pvt.Ltd.. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, allotment, and listing in one place.
Neochem Bio Solutions Limited IPO overview
Neochem Bio Solutions Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Neochem Bio Solutions Limited IPO important dates
Neochem Bio Solutions Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,35,200 |
| S-HNI (Min) | 3 | 3,600 | ₹3,52,800 |
| S-HNI (UPI) | 4 | 4,800 | ₹4,70,400 |
| S-HNI (Max) | 8 | 9,600 | ₹9,40,800 |
| B-HNI (Min) | 9 | 10,800 | ₹10,58,400 |
About Neochem Bio Solutions Limited IPO
From the company / RHP narrative.
The company products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.
The company offer a comprehensive range of textile and garment washing auxiliaries such as pre-treatment, dyeing, finishing, printing and coating applications across all fabric and garment substrates compatible with various processing machines.
The company has its manufacturing facility located at Saket Industrial Estate, Village Moraiya, Ta. Sanand, Dist-Ahmedabad, which has an installed capacity of 22,000 metric ton per annum (“MTPA”) with a total area of 6,763 square meters.
Competitve Strengths:
Strengthening the presence across end-user application industries
Commitment to continuous development of innovative performance chemistries and sustainable solutions
Continued focus on expansion of geographical presence
Leverage existing strategic collaborations and partnerships to diversify end user industries
Objective of the issue
How the issuer plans to use IPO proceeds.
Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company
General Corporate Purposes
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow IPO & unlisted research in the app, available on iOS and Android.